Dr. Pablo M. Bedano, MD
- Medicare services, 2024
- 1,328
- Medicare patients, 2024
- 454
- Part D claims, 2024
- 3,432
- Publications
- 2
- Clinical trials
- 6
- Practice address
- 1500 N Ritter Ave, Indianapolis, IN 46219
- Practice phone
- Call (317) 355-5411
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Bedano's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Pablo M. Bedano is a medical oncologist in Indianapolis, Indiana
Dr. Bedano practices at Community Hospital East in Indianapolis, Indiana, part of Community Health Network.
Dr. Bedano's NPI, 1063551240, was assigned on February 5, 2007. Dr. Bedano holds Indiana license 01061813A.
- NPI
- 1063551240NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8426156977
- NPI enumeration date
- February 5, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (317) 355-5411
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 52
- Medical school graduation
- 2000
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Pablo M. Bedano practices at Community Hospital East in Indianapolis, Indiana
Dr. Bedano's primary practice is Community Hospital East, at 1500 N Ritter Ave, Indianapolis, IN 46219 in Marion County. The practice phone is (317) 355-5411.
- Community Hospital East1500 N Ritter Ave, Indianapolis, IN 46219 · Marion CountyPhone(317) 355-5411
Source: Dmand AI Affiliation Data
Dr. Pablo M. Bedano is affiliated with 7 sites of care and 2 medical groups
Dr. Bedano's primary practice is Community Hospital East in Indianapolis, Indiana, part of Community Health Network. Dr. Bedano is also affiliated with Community Hospital North. The medical group on file is Community Physician Network. Dmand AI also links Dr. Bedano to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Pablo M. Bedano's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bedano practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Community Hospital East | Available with a free account |
| +6 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Community Health Network and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Pablo M. Bedano is one of 72 medical oncologists in Indiana
Medical oncology is Dr. Bedano's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Bedano is licensed in Indiana.
Specialties and state licenses
- Medical oncology, IndianaPrimary
Medical oncologists near Dr. Bedano
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Pablo M. Bedano billed Medicare for 1,328 services in 2024
CMS data shows 1,328 Medicare services from Dr. Bedano across 10 procedure codes in 2024, for 454 Medicare patients. Medicare paid $71,152 for them.
Dr. Bedano's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 9422024: 9966%
- Other services
- 2023: 02024: 332
Where Dr. Bedano's Medicare services took place, 2024
- In an office75357%
- In a facility57543%
Dr. Bedano compared with the Indiana median for medical oncologists, 2024
- Dr. Bedano
- Indiana median
- Medicare services
- 1,328vs 91445% above
- Medicare patients
- 454vs 33635% above
- Part D claims
- 2,897vs 6544.4 times
Medians across 72 medical oncologists in Indiana with Dmand AI profiles that report each measure.
Dr. Bedano's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Bedano?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Bedano and other medical oncologists in Indiana.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Pablo M. Bedano treated 454 Medicare patients in 2024, average age 73
CMS counts 454 Medicare patients who saw Dr. Bedano in 2024. The largest group is 65 to 74, with 194 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Bedano's median patient age at 70, with 51% women.
Dr. Bedano's Medicare patients by age, 2024
Dr. Bedano's Medicare patients by sex, 2024
- Women22349%
- Men23151%
Chronic conditions among Dr. Bedano's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis49%
- Chronic kidney disease43%
- Ischemic heart disease41%
- Anxiety39%
- Cancer39%
- Diabetes36%
Share of Medicare patients with each condition. A patient can have several.
Dr. Bedano's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women51%
- Men48%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Pablo M. Bedano wrote 3,432 Medicare Part D claims in 2024
In 2024, Dr. Bedano wrote 3,432 Medicare Part D claims for 628 patients. 73% of them were for generic drugs. CMS names the drug for 2,897 of them, across 70 drugs with 11 or more claims each, at $5,924,123 in total drug cost. In 2023, CMS named 2,791 claims across 62 drugs.
Dr. Bedano's Part D claims by kind of drug, 2024
- Generic2,513 claims73%
- Brand-name and other919 claims27%
Dr. Bedano's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Bedano's Part D claims, 2024
- Opioids4%148 of 3,432 claims
- Antibiotics5%162 of 3,432 claims
- Antipsychotics, patients 65 and over1%21 of 3,432 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2,7912024: 2,8974%
Drugs named by CMS: 70 in 2024, 62 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Pablo M. Bedano offers telehealth to Medicare patients
Dr. Bedano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bedano as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Pablo M. Bedano has 2 publications on record
Dmand AI links 2 papers to Dr. Bedano, published from 2010 to 2024. Dr. Bedano's most frequent co-authors are Eugene R. Ahn, MD, Olatunji B. Alese, MD and Rafat H. Ansari, MD.
Dr. Bedano's most frequent co-authors
Recent publications by Dr. Bedano
See who Dr. Bedano researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Bedano works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Pablo M. Bedano has worked on 6 clinical trials
Dmand AI links Dr. Bedano to 6 clinical trials, 4 of them phase 3 studies. 6 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Leukemia, Lymphocytic, Chronic, B-Cell. National Cancer Institute (NCI) sponsors the most, 4.
Conditions in Dr. Bedano's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Leukemia, Lymphocytic, Chronic, B-Cell
- Melanoma
- Leukemia, B-Cell
Investigators on the most trials with Dr. Bedano
- Spencer Henick Bachow, MD5 shared trials
- Umit Tapan, MD5 shared trials
- Sheetal Sumat Acharya, MD4 shared trials
Recent clinical trials with Dr. Bedano
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery (opens in a new tab)
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) (opens in a new tab)
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Pablo M. Bedano received $61,793 in industry payments from 2016 to 2025
CMS Open Payments shows 919 general payments to Dr. Bedano from 64 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. Merck Sharp & Dohme Corporation paid the most, $32,460.
General payments to Dr. Bedano by program year, 2016 to 2025
General payments to Dr. Bedano by kind, 2016 to 2025
- Speaker and faculty fees$27,63645%
- Consulting fees$17,16328%
- Food and beverage$13,62222%
- Honoraria$1,5002%
- Other$1,8733%
Companies that paid Dr. Bedano the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Pablo M. Bedano's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Pablo M. Bedano
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Pablo M. Bedano's NPI number?
Dr. Pablo M. Bedano's NPI number is 1063551240. It was assigned on February 5, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Pablo M. Bedano?
Dr. Pablo M. Bedano is a medical oncologist in Indianapolis, Indiana. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Pablo M. Bedano practice?
Dr. Bedano practices at 1500 N Ritter Ave, Indianapolis, IN 46219. Dr. Bedano's primary practice is Community Hospital East in Indianapolis, Indiana, part of Community Health Network. Dmand AI also links Dr. Bedano to 3 hospitals, 2 group practices and clinics and 1 medical group.
What is Dr. Pablo M. Bedano's office phone number?
The practice phone on file for Dr. Bedano is (317) 355-5411.
What is Dr. Pablo M. Bedano's medical license number?
Dr. Bedano holds Indiana license 01061813A.
Which hospitals is Dr. Pablo M. Bedano affiliated with?
Dr. Bedano practices at Community Hospital East in Indianapolis, Indiana. Dr. Bedano is also affiliated with Community Hospital North. Dmand AI links Dr. Bedano to 3 more hospitals.
What medical group is Dr. Pablo M. Bedano part of?
Dr. Bedano is linked to Community Physician Network. Dmand AI links Dr. Bedano to 1 more medical group.
Does Dr. Pablo M. Bedano accept Medicare?
Yes. CMS data shows Dr. Bedano billed Medicare for 1,328 services in 2024, and Dr. Bedano accepts Medicare assignment.
Does Dr. Pablo M. Bedano offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Bedano as offering telehealth services.
How many Medicare patients does Dr. Pablo M. Bedano see?
CMS counts 454 Medicare patients who saw Dr. Bedano in 2024, with an average age of 73.
Show 6 more questionsShow fewer questions
What services does Dr. Pablo M. Bedano bill to Medicare?
In 2024, Dr. Bedano's most billed Medicare services were medicare service (G2211), office visit, established patient (99213) and office visit, established patient (99214).
What drugs does Dr. Pablo M. Bedano prescribe most?
In 2024 Medicare Part D data, Dr. Bedano's most prescribed drugs by claims were Ondansetron HCl, Eliquis and Prochlorperazine Maleate.
Has Dr. Pablo M. Bedano received payments from drug or device companies?
CMS Open Payments shows $61,793 in general payments to Dr. Bedano from 64 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Pablo M. Bedano been practicing?
Dr. Bedano graduated from medical school in 2000, 26 years ago.
Does Dr. Pablo M. Bedano do research?
Dmand AI links 2 publications to Dr. Bedano, published from 2010 to 2024. Dr. Bedano has worked on 6 clinical trials.
Who does Dr. Pablo M. Bedano publish with?
Dr. Bedano's most frequent co-authors are Eugene R. Ahn, MD (1 shared paper), Olatunji B. Alese, MD (1 shared paper) and Rafat H. Ansari, MD (1 shared paper).
Selling to medical oncology practices?
See medical oncologists in Indiana by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card